Cellares – Talk Bio

Cellares’ cell therapy factory-in-a-box scores coveted advanced manufacturing technology tag from FDA

3 weeks ago talkbio0Tagged Advanced Manufacturing Technology, Biologics License Application, Cell Shuttle, Cell Therapy, Cellares, Identifier, Investigational New Drugs, production, Technology, United States Food and Drug Administration

Cell Therapy, Advanced Manufacturing Technology, United States Food and Drug Administration, Technology, Identifier, Cell Shuttle, production, Cellares, Biologics License Application, Investigational New Drugs

Bristol Myers and Cellares Collaborate on Global CAR-T Manufacturing Deal

12 months ago talkbio0Tagged Biopharma, CAR-T, Cellares, diversification, Generalized, Manufacture, Myers, Partner in relationship

Bristol Myers, Cellares, CAR-T, biopharma, manufacturing partners, diversification, global deal

BMS-Cellares Collaboration Spotlights U.S.-China Biopharma Rivalry

1 year ago talkbio0Tagged Biopharma, Burning Mouth Syndrome, Cancer Therapeutic Procedure, CAR-T, Cell Therapy, Cellares, Collaboration, rivalry, Tension, U.S.-China

BMS, Cellares, CAR-T, collaboration, U.S.-China tensions, biopharma rivalry, cell therapy, cancer treatment.

BMS Expands CAR-T Therapy Capabilities with Strategic $380 Million Investment in Cellares

1 year ago talkbio0Tagged Automation, Biotechnology, Burning Mouth Syndrome, Cancer Therapeutic Procedure, Capacity, CAR-T, Cell Therapy, Cellares, expansion, Investments, Manufacture, squibb

BMS, Bristol Myers Squibb, Cellares, CAR-T therapy, cell therapy, cancer treatment, biotechnology, investment, capacity expansion, manufacturing, automation.